Semaglutide Plus Metformin Improves Weight and Fertility in Obese PCOS Patients
Combining semaglutide with metformin produced significant weight loss and improved fertility outcomes in 20 obese PCOS patients with prediabetes.
Quick Facts
What This Study Found
Subcutaneous semaglutide combined with metformin produced significant weight loss and improved fertility outcomes in 20 consecutive PCOS patients with obesity and prediabetes.
Key Numbers
How They Did This
Pilot prospective study of 20 consecutive PCOS patients with obesity and prediabetes treated with semaglutide plus metformin, evaluating weight loss and fertility outcomes.
Why This Research Matters
PCOS affects 10% of women of reproductive age, and obesity worsens fertility outcomes. A treatment that addresses both weight and fertility simultaneously fills a critical gap.
The Bigger Picture
GLP-1 drugs may become standard preconception therapy for obese PCOS patients, addressing weight, insulin resistance, and fertility in one treatment approach.
What This Study Doesn't Tell Us
Small pilot study (n=20) without a control group. Prospective but not randomized or blinded. Short follow-up for fertility outcomes.
Questions This Raises
- ?Should semaglutide be stopped before conception or can it continue through early pregnancy?
- ?Does the fertility benefit persist after semaglutide discontinuation?
Trust & Context
- Key Stat:
- 20 patients, dual benefit Semaglutide + metformin improved both weight and fertility in obese PCOS
- Evidence Grade:
- Small pilot prospective study without control — provides encouraging preliminary data requiring larger RCT confirmation.
- Study Age:
- Published in 2026; explores an emerging indication for GLP-1 drugs.
- Original Title:
- Effect of semaglutide with metformin for weight loss and fertility in polycystic ovary syndrome (PCOS) patients with obesity: A pilot prospective study.
- Published In:
- Clinical nutrition ESPEN, 71, 102885 (2026)
- Authors:
- Bolek, Tomáš(2), Turňová, Petra, Janošova, Svetlana, Péč, Martin Jozef, Ságová, Ivana, Nagy, Norbert, Jurica, Jakub, Mokáň, Marián, Samoš, Matej
- Database ID:
- RPEP-14890
Evidence Hierarchy
Frequently Asked Questions
Can semaglutide help PCOS patients get pregnant?
This pilot study suggests semaglutide combined with metformin can improve both weight loss and fertility in obese PCOS patients. Larger studies are needed, and semaglutide should be stopped before pregnancy.
Why does weight loss improve PCOS fertility?
Excess weight worsens insulin resistance and hormonal imbalances in PCOS. Even modest weight loss (5-10%) can restore ovulation and significantly improve chances of conception.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14890APA
Bolek, Tomáš; Turňová, Petra; Janošova, Svetlana; Péč, Martin Jozef; Ságová, Ivana; Nagy, Norbert; Jurica, Jakub; Mokáň, Marián; Samoš, Matej. (2026). Effect of semaglutide with metformin for weight loss and fertility in polycystic ovary syndrome (PCOS) patients with obesity: A pilot prospective study.. Clinical nutrition ESPEN, 71, 102885. https://doi.org/10.1016/j.clnesp.2025.102885
MLA
Bolek, Tomáš, et al. "Effect of semaglutide with metformin for weight loss and fertility in polycystic ovary syndrome (PCOS) patients with obesity: A pilot prospective study.." Clinical nutrition ESPEN, 2026. https://doi.org/10.1016/j.clnesp.2025.102885
RethinkPeptides
RethinkPeptides Research Database. "Effect of semaglutide with metformin for weight loss and fer..." RPEP-14890. Retrieved from https://rethinkpeptides.com/research/bolek-2026-effect-of-semaglutide-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.